SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-16-132259
Filing Date
2016-11-08
Accepted
2016-11-08 08:06:36
Documents
61
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v451088_10q.htm 10-Q 442431
2 EXHIBIT 31.1 v451088_ex31-1.htm EX-31.1 9998
3 EXHIBIT 31.2 v451088_ex31-2.htm EX-31.2 9763
4 EXHIBIT 32.1 v451088_ex32-1.htm EX-32.1 4633
  Complete submission text file 0001144204-16-132259.txt   4302675

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT ampe-20160930.xml EX-101.INS 903095
6 XBRL TAXONOMY EXTENSION SCHEMA ampe-20160930.xsd EX-101.SCH 52131
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ampe-20160930_cal.xml EX-101.CAL 53254
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ampe-20160930_def.xml EX-101.DEF 262109
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE ampe-20160930_lab.xml EX-101.LAB 406129
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ampe-20160930_pre.xml EX-101.PRE 321512
Mailing Address 373 INVERNESS PARKWAY SUITE 200 ENGLEWOOD CO 80112
Business Address 373 INVERNESS PARKWAY SUITE 200 ENGLEWOOD CO 80112 720-437-6500
Ampio Pharmaceuticals, Inc. (Filer) CIK: 0001411906 (see all company filings)

IRS No.: 260179592 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35182 | Film No.: 161980015
SIC: 2834 Pharmaceutical Preparations